Showing results (21-30 of 214) with videos related to
Sort By:
Pageof 22
Therapeutic Advances in Gastroenterology|May 10, 2012
Secondary causes of nonalcoholic fatty liver diseaseJacob M Kneeman, Joseph Misdraji, Kathleen E CoreyComputers in Biology and Medicine|September 6, 2022
Visualizing biomarkers and their association with clinical outcomes: A machine learning approachHui Zheng, Robert E Gerszten, Kathleen E CoreyThe American Journal of Gastroenterology|November 26, 2003
Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett's esophagus? A meta-analysisKathleen E Corey, Sarah M Schmitz, Nicholas J ShaheenGastroenterology|December 11, 2020
AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achieve Weight Loss in the Management of Nonalcoholic Fatty Liver Disease: Expert ReviewZobair M Younossi, Kathleen E Corey, Joseph K LimCurrent Hepatology Reports|March 6, 2018
Managing the Burden of Non-NASH NAFLDChristopher J Danford, Jorge E Sanchez, Kathleen E CoreyThe Journal of International Medical Research|November 1, 1990
Bioavailability of single and multiple doses of enteric-coated mesalamine and sulphasalazineA E Corey, G M Rose, J D ConklinOral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics|August 1, 1997
Comparison of sublingually and orally administered triazolam for premedication before oral surgeryC W Berthold, R A Dionne, S E CoreyPediatric Nephrology (Berlin, Germany)|December 1, 1996
Improved renal allograft survival in children treated with FK 506 (tacrolimus) rescue therapyH E Corey, V Tellis, R Schechner, et al.Clinical Pharmacokinetics|March 7, 2000
Effect of multiple cilostazol doses on single dose lovastatin pharmacokinetics in healthy volunteersS L Bramer, J Brisson, A E Corey, et al.Clinical Liver Disease|February 8, 2021
Nonalcoholic Fatty Liver Disease and Cardiovascular DiseaseEric M Przybyszewski, Giovanni Targher, Michael Roden, et al.Pageof 22